Fate Therapeutics, Inc. financial statements, including revenue, expenses, profit, and loss
The total revenue of FATE for the last quarter is 3.07 M USD, and it's 54.61% lower compared to the previous quarter. The net income of Q3 24 is -47.68 M USD.